The government has increased enforcement against healthcare providers under the Controlled Substances Act (CSA). In addition to steep penalties, controlled substances violations may trigger patient care concerns, public relations challenges, carry years-long oversight and reporting requirements, and create enterprise risk. During this webinar, members of our Controlled Substances Enforcement & Diversion Task Force will discuss:

  • Recent government enforcement settlements under the CSA, trends and priorities
  • Impact of regulatory changes and guidance issued by the U.S. Drug Enforcement Administration (DEA) on healthcare providers
  • Best practices for responding to diversion events and unannounced DEA inspections
  • Tools to mitigate risk and ensure compliance

To register, click here


Submit your questions for presenters upon registration or email questions to Kendall Betts.

Who Should Attend?

  • In-house legal counsel
  • Compliance officers
  • Privacy officers
  • C-level executives, consultants and principals


Tennessee CLE
This program has been approved for one hour of General Tennessee CLE credit. Please provide your BPR number upon registration for Bass, Berry & Sims to report your participation to the Tennessee CLE Commission following the conference.

Other State CLE
Bass, Berry & Sims does not seek direct accreditation from states outside of Tennessee, but some states allow attorneys to earn credit through reciprocity or self-submission. Certificates of completion and other common supporting documents will be provided for use in jurisdictions outside of Tennessee.